The
slide to be stained for
CK7
comprised:
1. Kidney, 2. Gastric corpus, 3. Pancreas, 4. Lung adenocarcinoma,
5. Pancreas adenocarcinoma, 6. Colon adenocarcinoma. All tissues were fixed in 10 % neutral buffered formalin.
Criteria for assessing a CK7 staining as optimal included:
- A moderate to strong, distinct
cytoplasmic reaction of virtually all the epithelial cells of
the renal collecting ducts and the scattered epithelial cells in
the Bowman capsule.
- A moderate, distinct cytoplasmic reaction
of the majority of the foveolar epithelial cells of the stomach.
- A strong, distinct cytoplasmic reaction
of virtually all the epithelial cells of the large pancreatic
ducts while the epithelial cells of the intercalating ducts at
least should show a weak to moderate cytoplasmic reaction.
- A moderate to strong, distinct
cytoplasmic reaction in the majority of the neoplastic cells of
the lung and the pancreas adenocarcinoma.
- No reaction in the proximal tubules of
the kidney and the acinar cells of the pancreas.
130 laboratories participated in the
assessment. 86 % achieved a sufficient mark. The results are
summarized in Table 1.
Table 1.
Abs and scores for CK7, run 25
|
Concentrated Abs |
N |
Vendor |
Optimal |
Good |
Borderl. |
Poor |
Suff.1 |
Suff. OPS2 |
|
mAb clone
OV-TL 12/30 |
93
5
3
3
2
2
1
1 |
Dako
Novocastra
NeoMarkers
BioGenex
Euro Diagnostica
Monosan
Bio-Optica
Zymed |
46 |
48 |
14 |
2 |
86 % |
94 % |
|
mAb clone
K72.7 |
2
1 |
Biocare
NeoMarkers |
0 |
2 |
1 |
0 |
- |
- |
|
Ready-To-Use Abs |
|
|
|
|
|
|
|
|
|
mAb clone OV-TL
12/30 |
10 |
Ventana, 760-2224 |
7 |
3 |
0 |
0 |
100 % |
100 % |
|
mAb clone OV-TL
12/30 |
4 |
Dako, IR619 |
4 |
0 |
0 |
0 |
- |
- |
|
mAb clone OV-TL
12/30 |
2 |
Dako, N1626 |
0 |
1 |
0 |
1 |
- |
- |
|
mAb clone OV-TL
12/30 |
1 |
Linaris |
0 |
1 |
0 |
0 |
- |
- |
|
Total |
130 |
|
57 |
55 |
15 |
3 |
112 |
- |
|
Proportion |
|
|
44 % |
42 % |
12 % |
2 % |
86 % |
95 % |
1) Proportion of sufficient stains
(optimal or good), 2) Proportion of sufficient stains with optimal
protocol settings only, see below.
Following central protocol parameters were used to obtain an optimal
staining:
Concentrated Ab
mAb clone OV-TL 12/30: the protocols giving an optimal result
were based on either heat induced epitope retrieval (HIER) or
enzymatic pre-treatment.
Protocols based on HIER, used Tris-EDTA/EGTA pH 9 (22/36)*, Target
Retrieval Solution pH 9 (EnVision FLEX TRS high pH, Dako, (6/14)*, Cell
Conditioning 1 (BenchMark, Ventana) (3/7), Bond Epitope Retrieval
Solution 2 (Bond, Leica) (1/8), Target Retrieval Solution pH 6.1
(Dako) (1/2), or Citrate pH 6 (1/8) as retrieval buffer. The mAb was
typically diluted in the range of 1:50 – 1:800 depending on the
total sensitivity of the protocol employed. Using these protocol
settings 64 out of 67 (96 %)
laboratories produced a sufficient staining (optimal or good).
* (number of optimal results/number of
laboratories using this buffer)
Protocols based on enzymatic pre-treatment used the following
enzymes: Protease 1 (Benchmark, Ventana) (7/13), Proteinase K (Dako)
(2/5), Bond Enzyme 1 (Bond, Leica) (1/2), Protease 3 (Benchmark,
Ventana) (1/2), or Protease Type XIV Sigma (1/1). The mAb was
typically diluted in the range of 1:50 – 1:1.000 depending on the
total sensitivity of the protocol employed. Using these protocol
settings 19 out of 21 (90 %) laboratories produced a sufficient
staining.
Ready-To-Use Abs
Using the mAb clone OV-TL 12/30, prod. no. 760-2224, Ventana,
the protocols giving an optimal result were based either on HIER,
enzymatic pre-treatment or combined enzymatic pre-treatment end
HIER.
In the protocols using HIER, Cell Conditioning 1, mild, was used as
retrieval buffer and the incubation time for the primary Ab was 32
min and UltraView or iView were used as detection system. Using
these protocol settings 3 out of 3 (100 %) laboratories produced a
sufficient staining.
Using enzyme as pre-treatment, the optimal protocols were based on
Protease 1 for 4 or 8 min. The incubation time for the primary Ab
was 20 - 32 min and UltraView or iView were used as detection
system. Using these protocol settings 3 out of 3 (100 %)
laboratories produced a sufficient staining.
One optimal protocol was based on combined enzyme pre-treatment and
HIER. Protease 2 was used as enzymatic pre-treatment for 8 min, and
Cell Conditioning 1, short as HIER, the incubation time for the
primary Ab was 32 min and UltraView was used as the detection
system.
Using the mAb clone OV-TL 12/30, IR619, Dako, the protocols
giving an optimal result were all based on HIER using Target
Retrieval Solution pH 9 (EnVision FLEX TRS high pH) or Tris/EDTA pH 9 and an
incubation time in 20 min for the primary Ab and EnVision Flex as
the detection system. Using these protocol settings 4 out of 4 (100
%) laboratories produced a sufficient staining.
The most frequent cause of insufficient staining were:
- Too low concentration of the primary antibody
In this assessment the prevalent feature of an insufficient staining
was either a too weak general staining or a complete false negative
reaction of the structures supposed to be demonstrated. Virtually
all laboratories were able to demonstrate CK7 in high antigen
expressing structures as the large ducts of the pancreas and the
neoplastic cells of the pancreas adenocarcinoma, whereas the
neoplastic cells of the lung adenocarcinoma, the foveolar epithelial
cells of the stomach and the epithelial cells of the intercalating
ducts in the pancreas expressed less CK7 and was thus more
challenging and required an optimally calibrated protocol. In this
run both HIER and enzymatic pre-treatment could be used to obtain an
optimal staining, when the mAb clone OV-TL 12/30 was used. However
from a general perspective HIER should be preferred to eliminate or
reduce the influence of the fixation time in formalin, as enzymatic
pre-treatment in generel shall be adjusted to the fixation time in
formalin for an optimal result. In the optimal calibrated protocols
a CK7 reaction frequently was seen in scattered endothelial cells
and stromal cells. In this assessment pancreas was a recommended
control for CK7 providing the epithelial cells of the intercalating
ducts at least showed a weak to moderate reaction, while the acinar
cells were negative.
This
was the 2’ assessment of CK7 in NordiQC, as CK7 also was assessed in
run 8, 2003 and an identical proportion of sufficient results were
seen in the two runs as shown in table 2. This shows that the
immunohistochemical analysis for CK7 is relatively robust despite
the number of participants almost has been doubled and new material
has been circulated in this run.
Table 2:
Sufficient results with CK7 in two runs
| |
Run 8 2003 |
Run 25 2009 |
|
Participants, n= |
71 |
130 |
|
Sufficient results |
87 % |
86 % |
Conclusion
The mAb clone OV-TL 12/30 is a recommendable and robust marker for
CK7.
Both HIER and enzymatic pre-treatment can be used to obtain an
optimal staining for CK7. However HIER should be preferred to reduce
the influence of the formalin fixation time. Pancreas is recommended
as positive control in which the epithelial cells of the
intercalating ducts shall show an as strong as possible reaction,
while the acinar cells shall be negative. |